19564474

Source:http://linkedlifedata.com/resource/pubmed/id/19564474

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002199, umls-concept:C0008059, umls-concept:C0011854, umls-concept:C0232478, umls-concept:C0542341, umls-concept:C1280500
pubmed:issue	7
pubmed:dateCreated	2009-6-30
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00024518
pubmed:abstractText	To evaluate the safety and efficacy of ingested human recombinant interferon-alpha (hrIFN-alpha) for preservation of beta-cell function in young patients with recent-onset type 1 diabetes.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/UL1 RR024148, http://linkedlifedata.com/resource/pubmed/grant/Z01 DK062001-08, http://linkedlifedata.com/resource/pubmed/grant/Z01 DK062001-09, http://linkedlifedata.com/resource/pubmed/grant/ZIA DK062001-10, http://linkedlifedata.com/resource/pubmed/grant/ZIA DK062001-11
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-11552015, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-11798459, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-12610045, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-1289408, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-1531328, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-15839378, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-15919798, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-15972866, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-17940453, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-18421192, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-18716002, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-18843118, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-2088394, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-2210078, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-2656346, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-2903105, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-3045545, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-6386581, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-7956639, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-8208413, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-8845048, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-9160341, http://linkedlifedata.com/resource/pubmed/commentcorrection/19564474-9794112
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear, http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide, http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Placebos
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1935-5548
pubmed:author	pubmed-author:BrodStaley ASA, pubmed-author:BrownRebecca JRJ, pubmed-author:CampbellCarolC, pubmed-author:DuanZhigangZ, pubmed-author:HardinDana SDS, pubmed-author:HarlanDavid MDM, pubmed-author:McEvoyRobert CRC, pubmed-author:MoralesMiriam MMM, pubmed-author:OrlanderPhilip RPR, pubmed-author:PopovicJadrankaJ, pubmed-author:RotherKristina IKI, pubmed-author:WrightElizabethE
pubmed:issnType	Electronic
pubmed:volume	32
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1250-5
pubmed:dateRevised	2011-5-9
pubmed:meshHeading	pubmed-meshheading:19564474-Administration, Oral, pubmed-meshheading:19564474-Adolescent, pubmed-meshheading:19564474-Adult, pubmed-meshheading:19564474-Antibodies, Antinuclear, pubmed-meshheading:19564474-C-Peptide, pubmed-meshheading:19564474-Child, pubmed-meshheading:19564474-Child, Preschool, pubmed-meshheading:19564474-Diabetes Mellitus, Type 1, pubmed-meshheading:19564474-Diabetic Nephropathies, pubmed-meshheading:19564474-Double-Blind Method, pubmed-meshheading:19564474-Eating, pubmed-meshheading:19564474-Humans, pubmed-meshheading:19564474-Immunologic Factors, pubmed-meshheading:19564474-Insulin-Secreting Cells, pubmed-meshheading:19564474-Interferon-alpha, pubmed-meshheading:19564474-Placebos, pubmed-meshheading:19564474-Young Adult
pubmed:year	2009
pubmed:articleTitle	Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes.
pubmed:affiliation	National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA. kr58q@nih.gov
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural